Our most recent GIST Days of Learning (GDOLs) were in-person again! Deputy Director, Laura Occhiuzzi and Senior Director of Outreach & Engagement Diana Nieves traveled to San Diego and Miami to meet with GIST experts and members of our community.
In this webinar, “The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor”, Dr. Bialick discussed recent data looking at treatment outcomes based off KIT resistant mutations identified by circulating tumor DNA in patients with GIST.
Dr. Gina D'Amato, Sylvester Comprehensive Cancer Center University and Dr. Breelyn WIlky, University of Colorado Cancer Center, presented Management of GIST & Treatment-related Symptoms at Life Fest 2022 in New Orleans.
Dr. Gina D'Amato, who appeared recently as moderator and contributor for the first Women in Sarcoma discussion panel, recorded a video discussing the use of liquid biopsy in sarcoma on OncTV for OncLive.
Miami GDOL On Saturday, March 25th, The Life Raft Group held the first 2017 GIST Day of Learning, also known as “GDOL,” in Miami, Florida. GDOLs are free, one-day programs that provide both education [...]
New York, NY and Wayne, NJ - January 12, 2017 Columbia University Medical Center, NewYork-Presbyterian and the Life Raft Group (LRG), a patient advocacy organization specializing in GIST cancer, announced today that they have [...]
The Life Raft Group is pleased to announce the release of the tenth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as [...]
The Life Raft Group kicked off its 2016 GIST Day of Learning (GDOL) series this spring with events from coast to coast. GDOLs are free, one-day programs that provide both education and support for the GIST [...]
Drs. Breelyn Wilky, Jonathan Trent, AlanLivingstone, and Pablo Bejarano show off theirrare in Miami. The 2015 GIST Days of Learning Tour continues to be successful. A GIST Day of Learning (GDOL) is [...]
GIST advocates from around the world gathered in Miami for the annual New Horizons conference. This international meeting was launched by Novartis Oncology in 2003 with the title, “New Horizons in Treating CML and [...]
